The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, multicenter, open-label study of HSK42360, a brain-penetrant BRAF inhibitor, in patients with BRAF V600-mutated solid tumors.
 
Jian Li
No Relationships to Disclose
 
Ting Xu
No Relationships to Disclose
 
Weizhen Zhang
No Relationships to Disclose
 
Wenbin Li
No Relationships to Disclose
 
Zhuang Kang
No Relationships to Disclose
 
Zhenchao Yuan
No Relationships to Disclose
 
Wei Jiang
No Relationships to Disclose
 
Xianan Li
No Relationships to Disclose
 
Yongchang Zhang
No Relationships to Disclose
 
De-zhi Kang
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Bing Xia
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Yu Xu
No Relationships to Disclose
 
Shikai WU
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)